Compare LTRX & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LTRX | ANIK |
|---|---|---|
| Founded | 1989 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Communications Equipment | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 236.4M | 200.9M |
| IPO Year | 2000 | 1996 |
| Metric | LTRX | ANIK |
|---|---|---|
| Price | $5.71 | $21.43 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | $6.50 | ★ $17.00 |
| AVG Volume (30 Days) | ★ 677.7K | 120.7K |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 80.16 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $122,923,000.00 | $112,819,000.00 |
| Revenue This Year | $1.12 | $5.98 |
| Revenue Next Year | $15.27 | $7.42 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.58 | $8.56 |
| 52 Week High | $8.75 | $22.88 |
| Indicator | LTRX | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | 46.31 | 62.80 |
| Support Level | $5.60 | $14.13 |
| Resistance Level | $6.09 | $22.88 |
| Average True Range (ATR) | 0.34 | 1.19 |
| MACD | -0.01 | -0.06 |
| Stochastic Oscillator | 9.57 | 61.08 |
Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.
Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.